No other prior malignancy within the past 2 years except nonmelanoma skin cancer or carcinoma in situ of any site

No history of allergic reactions attributed to compounds of similar chemical or biologic composition to fenretinide

No other concurrent uncontrolled illness (e.g., ongoing or active infection)

No concurrent psychiatric illness or social situation that would preclude study

History of HIV allowed if no active infection or history of retinitis

No history of retinal disease, night blindness, or difficulty seeing in the dark

PRIOR CONCURRENT THERAPY:

Biologic therapy:

Prior biologic therapy allowed

Chemotherapy:

No more than 1 prior chemotherapy regimen

Endocrine therapy:

Not specified

Radiotherapy:

See Disease Characteristics

At least 4 weeks since prior radiotherapy

Surgery:

See Disease Characteristics

Other:

Recovered from prior therapy

No prior systemic retinoid therapy

No concurrent antioxidants (e.g., ascorbic acid or vitamin E)

No other concurrent therapy for renal cell carcinoma

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00011973